Nicholas Galakatos, 10% Owner at PONIARD PHARMACEUTICALS, INC. (PARD), sold 494,962 shares at $8.06 ($4.1M) on 2009-11-06, disclosed to the SEC on 2009-11-09.
Scheduled sale ($4.1M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 78,262 | $626K | 15.5% |
| 2 | $8.06 | 264,648 | $2.1M | 52.6% |
| 3 | $8.50 | 152,052 | $1.3M | 31.9% |
| Total | $8.19 avg | 494,962 | $4.1M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |